1 General Information
The Swiss Life Group is one of Europe’s leading comprehensive life and pensions and financial solutions providers. In its core markets of Switzerland, France and Germany, Swiss Life offers individuals and corporations comprehensive and individual advice plus a broad range of own and partner products through its sales force and distribution partners such as brokers and banks.
Swiss Life Select, Tecis, Horbach, Proventus and Chase de Vere advisors choose suitable products for customers from the market. Swiss Life Asset Managers offers institutional and private investors access to investment and asset management solutions. Swiss Life provides multinational corporations with employee benefits solutions and high net worth individuals with structured life and pensions products.
Dividend payment
For the 2023 financial year, a dividend of CHF 945 million (CHF 33.00 per registered share) was paid in May 2024 to the shareholders of Swiss Life Holding Ltd (hereinafter referred to as “Swiss Life Holding”).
Share buyback programme
As announced on 3 December 2024, Swiss Life started a CHF 750 million share buyback programme in December 2024. By 31 December 2024, 57 187 shares had been purchased at an average price of CHF 690.29 per share. The programme will be completed in May 2026.
As announced on 6 September 2023, Swiss Life started a CHF 300 million share buyback programme in October 2023. By 28 March 2024, 502 081 shares had been purchased at an average price of CHF 597.51 per share, of which 261 800 shares for CHF 150 million were purchased in 2023. The programme was completed in March 2024.
As announced during the Investor Day on 25 November 2021, Swiss Life started a CHF 1 billion share buyback programme in December 2021. By 30 May 2023, 1 876 368 shares had been purchased at an average price of CHF 532.94 per share, of which 472 487 shares for CHF 262 million were purchased in 2023, 1 335 881 shares for CHF 701 million in 2022 and 68 000 shares for CHF 38 million in 2021. The programme was completed in May 2023.
Approval of financial statements
On 4 April 2025, the Board of Directors approved the annual financial statements and the financial report and authorised them for issue. The financial report, therefore, only reflects events up to that date.